|
|
Establishment and characterization of a Paraquat-resistant human lung adenocarcinoma cell line A549/PQ |
Department of Emergency Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015 |
|
Cite this article: |
HONG Guangliang,TAN Jiaping,DING Yingwei, et al. Establishment and characterization of a Paraquat-resistant human lung adenocarcinoma cell line A549/PQ[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2015, 45(11): 781-.
|
|
Abstract Objective: To establish Paraquat (PQ)-resistant A549 cell line (A549/PQ) and explore its biological characteristics. Methods: The A549 cells were periodically co-cultured with PQ at gradually increasing concentrations, and its biological characteristics were observed. The morphological features were checked with light microscope. Sensitivity to PQ was detected by LDH assay. The cell growth curve and doubling time were studied by cell counting. CCK-8 assay was used to measure the median inhibitory concentration (IC50) and resistance index (RI) of A549/PQ cells and flow cytometry was applied to evaluate the cells cycle distribution. Results: Compared with A549 cells, the changes for larger size, irregular shape and much wide cell gap were found in A549/PQ cells. LDH release induced by PQ in A549/PQ cells was significantly lower than that of A549 cells (P<0.05). CCK-8 assay showed higher IC50 in A549/PQ cells than that in A549 cells (1716.33 ﹠ 215.03 μmol/L, P<0.05) and RI was 7.98 in A549/PQ cells. Longer doubling time, increased G0/G1 phase cells and decreased cells in S phase were found in A549 cells (P<0.05). Conclusion: We successfully constructed a PQ-resistant A549 cell line with significantly different biological characteristics and therefore a good cellular model for PQ toxicity research.
|
Received: 01 February 2015
|
|
|
|
|
[1] Gawarammana IB, Buckley NA. Medical management of paraquat ingestion[J]. Br J Clin Pharmacol, 2011, 72(5): 745-757.
[2] Dinis-Oliveira RJ, Duarte JA, Sánchez-Navarro A, et al.Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment[J]. Crit Rev Toxicol, 2008, 38(1):13-71.
[3] 中国医师协会急诊医师分会. 急性百草枯中毒诊治专家 共识(2013)[J]. 中国急救医学, 2013, 33(6): 484-489.
[4] An J, Shen X, Ma Q, et al. Transcriptome profiling to discover putative genes associated with paraquat resistance in goosegrass (Eleusine indica L.)[J]. PLoS One, 2014, 9(6): e99940.
[5] Fujita M, Fujita Y, Iuchi S, et al. Natural variation in a polyamine transporter determines paraquat tolerance in Arabidopsis[J]. Proc Natl Acad Sci USA, 2012, 109(16): 6343-6347.
[6] 蒋东海. 新型乳腺癌耐药细胞的建立、鉴定及耐药逆转[D]. 杭州: 浙江大学, 2011: 9-11.
[7] Negoro K, Yamano Y, Fushimi K, et al. Establishment and characterization of a cisplatin-resistant cell line, KB-R, derived from oral carcinoma cell line, KB[J]. Int J Oncol,2007, 30(6): 1325-1332.
[8] 王建军, 赵晖, 林峰, 等. 耐甲氨蝶呤人骨肉瘤细胞株建立及其生物学特性[J]. 肿瘤, 2007, 27(8): 623-627.
[9] 董梅, 林晨, 冯奉仪, 等. 人肺腺癌吉西他滨耐药细胞系的 建立及其特性[J]. 癌症, 2004, 23(6): 667-671.
[10] 张会军, 阎蕴力, 郑力芬, 等. 人小细胞肺癌多药耐药细胞系H446/VP的建立及其生物学性状[J]. 肿瘤, 2004, 24 (3): 233-236.
[11] 陈公琰, 杨朝阳, 洪璇, 等. 人肺腺癌耐药细胞模型的建立及生物学特性的初步鉴定[J]. 中华医学杂志, 2007, 87(13): 924-926.
[12] Snow K, Judd W. Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines[J]. Br J Cancer,1991, 63(1): 17-28.
[13] 张宝兰, 姚朗, 欧艺. 1991-2008年我国百草枯中毒文献分析[J]. 中国急救医学, 2010, 30(2): 139-141.
[14] 卢中秋, 洪广亮, 赵光举, 等. 百草枯急性中毒救治中的几个焦点问题[J]. 中华劳动卫生职业病杂志, 2013, 31(5): 395-397.
[15] 彭晓东, 陈骥, 梁创. 急性百草枯中毒后MODS患者血清TNF-α和IL-10的变化及意义[J]. 中国实用医药, 2008, 3(14): 9-11.
[16] 卢中秋, 贺晓艳, 洪广亮, 等. 二巯丙磺钠对急性百草枯中毒大鼠肺损伤的保护作用[J]. 中华内科杂志, 2009, 48 (3): 233-234.
[17] Hong GL, Liu JM, Zhao GJ, et al. The reversal of paraquat-induced mitochondria-mediated apoptosis by cycloartenyl ferulate, the important role of Nrf2 pathway[J]. Exp Cell Res, 2013, 319(18): 2845-2855.
[18] Cai Q, Lu Z, Hong G, et al. Recombinant adenovirus AdRUNrf2 reduces paraquat-induced A549 injury[J]. Hum Exp Toxicol, 2012, 31(11): 1102-1112.
|
|
|
|